Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software
recent articles
From Deciphex on LinkedIn: Big News! 🎉 We’re proud to share that Deciphex has been ranked 8th on LinkedIn’s Top Startups 2024 list for Ireland! This recognition is a testament to our work in advancing digital pathology and...
From the Proscia blog: Following a successful year-long pilot with a subset of our biopharma and biotech partners, today we announced that life sciences organizations can now leverage Proscia’s real-world data offering on the...
Ibex Survey discovers that more than 50% of Americans have received incorrect medical test results for themselves or a loved one; 60% would trust AI supporting diagnoses BOSTON, Sept. 25, 2024 — Ibex Medical Analytics (Ibex), the...
The shareholders, the Board of Directors, the management of Cytomine Corporation SA are very sad to inform you about the closing of its activities at the end of July ’24. The projected capital increase with new investors was...
Gestalt and DataPath: The companies are focused on making an impact on healthcare accessibility SPOKANE, Wash., Sept. 16, 2024 /PRNewswire/ -- Gestalt, a leader in AI-driven digital pathology solutions, is excited to announce its...
Dublin, 16th September 2024 — Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation. VICT3R is a public-private partnership supported by the...
